Albireo Pharma (ALBO) 10-Q 2009 Q2 Quarterly report

Exhibit 32.01

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report on Form 10-Q of Biodel Inc. (the “Company”) for the fiscal quarter ended June 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned Solomon S. Steiner, President and Chief Executive Officer of the Company and Gerard Michel, Chief Financial Officer of the Company, each hereby certifies that: (1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 7, 2009	/s/ Solomon S. Steiner
	Solomon S. Steiner, Chairman, President and
	Chief Executive Officer
Dated: August 7, 2009	/s/ Gerard Michel
	Gerard Chief Financial Officer,
	VP Corporate Development, and Treasurer